{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T09:29:47Z","timestamp":1784971787403,"version":"3.55.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"University Hospital of Reims"},{"DOI":"10.13039\/501100016399","name":"University of Reims Champagne-Ardenne","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100016399","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-14994-x","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T13:21:55Z","timestamp":1758806515000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Association between exacerbation history and airway bacterial community assessed by extended bacterial culture and sequencing approaches in stable COPD"],"prefix":"10.1038","volume":"15","author":[{"given":"Quentin","family":"Lecomte-Thenot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne-Marie","family":"Perotin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevi\u00e8ve","family":"H\u00e9ry-Arnaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lourdes","family":"V\u00e9lo-Suarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Brisebarre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Clarenne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Gouriou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Dury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ga\u00ebtan","family":"Desl\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana\u00eblle","family":"Muggeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Guillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"The RINNOPARI Study Group includes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Abely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Ancel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Birembaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Brisebarre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"de Champs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzague","family":"Del\u00e9pine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rian","family":"Dormoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Dury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Launois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Le Naour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Lebargy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Mauran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Claude","family":"M\u00e9rol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Mulette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne-Marie","family":"Perotin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam","family":"Polette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,25]]},"reference":[{"issue":"2","key":"14994_CR1","doi-asserted-by":"publisher","first-page":"e16384","DOI":"10.1371\/journal.pone.0016384","volume":"6","author":"JR Erb-Downward","year":"2011","unstructured":"Erb-Downward, J. R. et al. Analysis of the lung Microbiome in the \u00ab healthy \u00bb smoker and in COPD. PloS One . 6 (2), e16384 (2011).","journal-title":"PloS One 22 F\u00e9vr"},{"key":"14994_CR2","doi-asserted-by":"crossref","unstructured":"Charlson, E. S. et al. Topographical continuity of bacterial populations in the healthy human respiratory tract. Am. J. Respir Crit. Care Med. 15 (8), 957\u2013963 (2011).","DOI":"10.1164\/rccm.201104-0655OC"},{"issue":"6","key":"14994_CR3","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1513\/AnnalsATS.201501-029OC","volume":"12","author":"RP Dickson","year":"2015","unstructured":"Dickson, R. P. et al. Spatial variation in the healthy human lung Microbiome and the adapted Island model of lung biogeography. Ann. Am. Thorac. Soc. . 12 (6), 821\u2013830 (2015).","journal-title":"Ann. Am. Thorac. Soc. Juin"},{"key":"14994_CR4","doi-asserted-by":"crossref","unstructured":"Morris, A. et al. Comparison of the Respiratory Microbiome in Healthy Nonsmokers and Smokers. Am. J. Respir. Crit. Care Med. 187(10), 1067\u201375. (2013).","DOI":"10.1164\/rccm.201210-1913OC"},{"key":"14994_CR5","doi-asserted-by":"crossref","unstructured":"Sze, M. A. et al. The lung tissue microbiome in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 185(10), 1073\u201380. (2012).","DOI":"10.1164\/rccm.201111-2075OC"},{"key":"14994_CR6","doi-asserted-by":"crossref","unstructured":"Kim, H. J. et al. The microbiome of the lung and its extracellular vesicles in nonsmokers, healthy smokers and COPD patients. Exp Mol Med. 49(4):e316. (2017).","DOI":"10.1038\/emm.2017.7"},{"issue":"1","key":"14994_CR7","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1080\/1040841X.2018.1549019","volume":"45","author":"C Lamoureux","year":"2019","unstructured":"Lamoureux, C., Guilloux, C. A., Beauruelle, C., Jolivet-Gougeon, A. & H\u00e9ry-Arnaud, G. Anaerobes in cystic fibrosis patients\u2019 airways. Crit. Rev. Microbiol. . 45 (1), 103\u2013117 (2019).","journal-title":"Crit. Rev. Microbiol. F\u00e9vr"},{"key":"14994_CR8","doi-asserted-by":"publisher","unstructured":"Dickson, R. P. et al. Bacterial topography of the healthy human lower respiratory tract. mBio . 8 (1). https:\/\/doi.org\/10.1128\/mbio.02287-16 (2017).","DOI":"10.1128\/mbio.02287-16"},{"key":"14994_CR9","unstructured":"H\u00e9ry-Arnaud, G. & Soci\u00e9t\u00e9 Fran\u00e7aise de, M. [cit\u00e9 27 ao\u00fbt 2024]. Le microbiote pulmonaire, un enjeu r\u00e9cent en microbiologie m\u00e9dicale. Disponible sur: https:\/\/www.sfm-microbiologie.org\/2020\/06\/10\/9870( 2020)."},{"issue":"4","key":"14994_CR10","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1111\/imm.12159","volume":"140","author":"D Karmarkar","year":"2013","unstructured":"Karmarkar, D. & Rock, K. L. Microbiota signalling through MyD88 is necessary for a systemic neutrophilic inflammatory response. Immunol.. 140 (4), 483\u2013492 (2013).","journal-title":"Immunol. D\u00e9c"},{"issue":"12","key":"14994_CR11","doi-asserted-by":"publisher","first-page":"e113466","DOI":"10.1371\/journal.pone.0113466","volume":"9","author":"Y Yun","year":"2014","unstructured":"Yun, Y. et al. Environmentally determined differences in the murine lung microbiota and their relation to alveolar architecture. PloS One. 9 (12), e113466 (2014).","journal-title":"PloS One"},{"issue":"1","key":"14994_CR12","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1038\/s41467-017-01803-x","volume":"8","author":"RL Brown","year":"2017","unstructured":"Brown, R. L., Sequeira, R. P. & Clarke, T. B. The microbiota protects against respiratory infection via GM-CSF signaling. Nat. Commun.. 8 (1), 1512 (2017).","journal-title":"Nat. Commun. 15 Nov"},{"issue":"10","key":"14994_CR13","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/S2213-2600(18)30510-1","volume":"7","author":"KF Budden","year":"2019","unstructured":"Budden, K. F. et al. Functional effects of the microbiota in chronic respiratory disease. Lancet Respir Med.  7 (10), 907\u2013920 (2019).","journal-title":"Lancet Respir Med. Oct."},{"issue":"1","key":"14994_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/1040841X.2020.1830748","volume":"47","author":"J Liu","year":"2021","unstructured":"Liu, J. et al. Role of pulmonary microorganisms in the development of chronic obstructive pulmonary disease. Crit. Rev. Microbiol. 2 Janv. 47 (1), 1\u201312 (2021).","journal-title":"Crit. Rev. Microbiol. 2 Janv"},{"key":"14994_CR15","unstructured":"Global Initiative for Chronic Obstructive Lung Disease [Internet]. (2024 Gold reports). Disponible sur:  https:\/\/goldcopd.org\/2024-gold-report\/(2024)."},{"issue":"116","key":"14994_CR16","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1183\/09059180.00002610","volume":"19","author":"A Anzueto","year":"2010","unstructured":"Anzueto, A. Impact of exacerbations on COPD. Eur. Respir Rev.. 19 (116), 113\u2013118 (2010).","journal-title":"Eur. Respir Rev. 1 Juin"},{"issue":"3","key":"14994_CR17","doi-asserted-by":"publisher","first-page":"1602265","DOI":"10.1183\/13993003.02265-2016","volume":"50","author":"JA Wedzicha","year":"2017","unstructured":"Wedzicha, J. A. et al. Prevention of COPD exacerbations: a European respiratory society\/american thoracic society guideline. Eur. Respir J.. 50 (3), 1602265 (2017).","journal-title":"Eur. Respir J. Sept"},{"issue":"3","key":"14994_CR18","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1136\/thx.2005.041822","volume":"61","author":"E Sapey","year":"2006","unstructured":"Sapey, E. & Stockley, R. A. COPD exacerbations. 2: aetiology. Thorax Mars. 61 (3), 250\u2013258 (2006).","journal-title":"Thorax Mars"},{"issue":"7","key":"14994_CR19","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1111\/resp.12780","volume":"21","author":"FW Ko","year":"2016","unstructured":"Ko, F. W. et al. Acute exacerbation of COPD. Respirology 21 (7), 1152\u20131165 (2016).","journal-title":"Respirology"},{"key":"14994_CR20","doi-asserted-by":"crossref","unstructured":"Molyneaux, P. L. et al. Outgrowth of the bacterial airway Microbiome after rhinovirus exacerbation of chronic obstructive pulmonary disease. Am. J. Respir Crit. Care Med. 15 (10), 1224\u20131231 (2013).","DOI":"10.1164\/rccm.201302-0341OC"},{"issue":"3","key":"14994_CR21","doi-asserted-by":"publisher","first-page":"166","DOI":"10.4046\/trd.2023.0015","volume":"86","author":"DD Sin","year":"2023","unstructured":"Sin, D. D. Chronic obstructive pulmonary disease and the airway microbiome: what respirologists need to know. Tuberc Respir Dis. . 86 (3), 166\u2013175 (2023).","journal-title":"Tuberc Respir Dis. Juill"},{"key":"14994_CR22","doi-asserted-by":"publisher","first-page":"127244","DOI":"10.1016\/j.micres.2022.127244","volume":"266","author":"S Yu","year":"2023","unstructured":"Yu, S. et al. The association between the respiratory tract Microbiome and clinical outcomes in patients with COPD. Microbiol. Res.. 266, 127244 (2023).","journal-title":"Microbiol. Res. 1 Janv"},{"issue":"1","key":"14994_CR23","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jaci.2020.02.040","volume":"147","author":"AJ Dicker","year":"2021","unstructured":"Dicker, A. J. et al. The sputum microbiome, airway inflammation, and mortality in chronic obstructive pulmonary disease. J. Allergy Clin. Immunol.. 147 (1), 158\u2013167 (2021).","journal-title":"J. Allergy Clin. Immunol. Janv"},{"issue":"3","key":"14994_CR24","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.cll.2013.03.001","volume":"33","author":"TC Dingle","year":"2013","unstructured":"Dingle, T. C. & Butler-Wu, S. M. Maldi-tof mass spectrometry for microorganism identification. Clin. Lab. Med.. 33 (3), 589\u2013609 (2013).","journal-title":"Clin. Lab. Med. Sept"},{"key":"14994_CR25","doi-asserted-by":"publisher","first-page":"781797","DOI":"10.3389\/fmicb.2021.781797","volume":"12","author":"A Muggeo","year":"2021","unstructured":"Muggeo, A. et al. Extended bacteria Culture-Based clustering identifies a phenotype associating increased cough and enterobacterales in stable chronic obstructive pulmonary disease. Front. Microbiol.. 12, 781797 (2021).","journal-title":"Front. Microbiol. 14 D\u00e9c"},{"issue":"3","key":"14994_CR26","first-page":"177","volume":"5","author":"GR Washko","year":"2008","unstructured":"Washko, G. R. et al. Computed Tomographic-Based quantification of emphysema and correlation to pulmonary function and mechanics. COPD J. Chronic Obstr. Pulm Dis. . 5 (3), 177\u2013186 (2008).","journal-title":"COPD J. Chronic Obstr. Pulm Dis. Janv"},{"issue":"1","key":"14994_CR27","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s12931-014-0151-9","volume":"15","author":"JM Perotin","year":"2014","unstructured":"Perotin, J. M. et al. Delay of airway epithelial wound repair in COPD is associated with airflow obstruction severity. Respir Res. . 15 (1), 151 (2014).","journal-title":"Respir Res. D\u00e9c"},{"issue":"7","key":"14994_CR28","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nmeth.3869","volume":"13","author":"BJ Callahan","year":"2016","unstructured":"Callahan, B. J. et al. DADA2: High-resolution sample inference from illumina amplicon data. Nat. Methods . 13 (7), 581\u2013583 (2016).","journal-title":"Nat. Methods Juill"},{"issue":"11","key":"14994_CR29","doi-asserted-by":"publisher","first-page":"5607","DOI":"10.1099\/ijsem.0.004332","volume":"70","author":"AC Parte","year":"2020","unstructured":"Parte, A. C., Sard\u00e0 Carbasse, J., Meier-Kolthoff, J. P., Reimer, L. C. & G\u00f6ker, M. List of prokaryotic names with standing in nomenclature (LPSN) moves to the DSMZ. Int. J. Syst. Evol. Microbiol. 70 (11), 5607\u20135612 (2020).","journal-title":"Int. J. Syst. Evol. Microbiol."},{"issue":"1","key":"14994_CR30","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s10096-019-03716-7","volume":"39","author":"E Farfour","year":"2020","unstructured":"Farfour, E. et al. Accurate identification of S. pneumoniae using MALDI-TOF mass spectrometry, still a challenge for clinical laboratories? Eur. J. Clin. Microbiol. Infect. Dis. . 39 (1), 209\u2013211 (2020).","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis. Janv"},{"issue":"4","key":"14994_CR31","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1136\/thoraxjnl-2019-214168","volume":"75","author":"B Ditz","year":"2020","unstructured":"Ditz, B. et al. Sputum Microbiome profiling in COPD: beyond singular pathogen detection. Thorax . 75 (4), 338\u2013344 (2020).","journal-title":"Thorax Avr"},{"issue":"5","key":"14994_CR32","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1136\/thoraxjnl-2011-201183","volume":"67","author":"MK Han","year":"2012","unstructured":"Han, M. K. et al. Significance of the Microbiome in obstructive lung disease. Thorax . 67 (5), 456\u2013463 (2012).","journal-title":"Thorax Mai"},{"issue":"2","key":"14994_CR33","doi-asserted-by":"publisher","first-page":"1801711","DOI":"10.1183\/13993003.01711-2018","volume":"53","author":"RL Watson","year":"2019","unstructured":"Watson, R. L., De Koff, E. M. & Bogaert, D. Characterising the respiratory Microbiome. Eur. Respir J. . 53 (2), 1801711 (2019).","journal-title":"Eur. Respir J. F\u00e9vr"},{"issue":"21","key":"14994_CR34","doi-asserted-by":"publisher","first-page":"3887","DOI":"10.1002\/1873-3468.12353","volume":"590","author":"K Shima","year":"2016","unstructured":"Shima, K., Coopmeiners, J., Graspeuntner, S., Dalhoff, K. & Rupp, J. Impact of micro-environmental changes on respiratory tract infections with intracellular bacteria. FEBS Lett. . 590 (21), 3887\u20133904 (2016).","journal-title":"FEBS Lett. Nov"},{"issue":"7","key":"14994_CR35","doi-asserted-by":"publisher","first-page":"e0159066","DOI":"10.1371\/journal.pone.0159066","volume":"11","author":"SW Lee","year":"2016","unstructured":"Lee, S. W., Kuan, C. S., Wu, L. S. H. & Weng, J. T. Y. Metagenome and metatranscriptome profiling of moderate and severe COPD sputum in Taiwanese Han males. Tunney M, \u00e9diteur. PLOS ONE . 11 (7), e0159066 (2016).","journal-title":"PLOS ONE 18 Juill"},{"issue":"2","key":"14994_CR36","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1002\/kjm2.12147","volume":"36","author":"Z Sun","year":"2020","unstructured":"Sun, Z., Zhu, Q., Shen, Y., Yan, T. & Zhou, X. Dynamic changes of gut and lung microorganisms during chronic obstructive pulmonary disease exacerbations. Kaohsiung J. Med. Sci. . 36 (2), 107\u2013113 (2020).","journal-title":"Kaohsiung J. Med. Sci. F\u00e9vr"},{"issue":"12","key":"14994_CR37","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/S2213-2600(14)70213-9","volume":"2","author":"GB Rogers","year":"2014","unstructured":"Rogers, G. B., Bruce, K. D., Martin, M. L., Burr, L. D. & Serisier, D. J. The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial. Lancet Respir Med.. 2 (12), 988\u2013996 (2014).","journal-title":"Lancet Respir Med. D\u00e9c"},{"key":"14994_CR38","doi-asserted-by":"publisher","first-page":"1037037","DOI":"10.3389\/fmicb.2022.1037037","volume":"13","author":"X Dang","year":"2022","unstructured":"Dang, X. et al. Frequent exacerbators of chronic obstructive pulmonary disease have distinguishable sputum Microbiome signatures during clinical stability. Front. Microbiol. . 13, 1037037 (2022).","journal-title":"Front. Microbiol. 1 D\u00e9c"},{"issue":"1","key":"14994_CR39","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1186\/s12931-022-02246-9","volume":"23","author":"W Li","year":"2022","unstructured":"Li, W. et al. Analysis of sputum microbial metagenome in COPD based on exacerbation frequency and lung function: a case control study. Respir Res. . 23 (1), 321 (2022).","journal-title":"Respir Res. 19 Nov"},{"key":"14994_CR40","doi-asserted-by":"crossref","unstructured":"Yang, C. Y. et al. Association of exacerbation phenotype with the sputum microbiome in chronic obstructive pulmonary disease patients during the clinically stable state. J. Transl. Med. 19(1), 121. (2021).","DOI":"10.1186\/s12967-021-02788-4"},{"issue":"1","key":"14994_CR41","first-page":"00595","volume":"10","author":"AA Pragman","year":"2024","unstructured":"Pragman, A. A. et al. Sputum Microbiome \u03b1-diversity is a key feature of the COPD frequent exacerbator phenotype. ERJ Open. Res.. 10 (1), 00595\u20132023 (2024).","journal-title":"ERJ Open. Res. Janv"},{"issue":"1","key":"14994_CR42","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12890-019-0867-x","volume":"19","author":"L Millares","year":"2019","unstructured":"Millares, L. et al. Relationship between the respiratory Microbiome and the severity of airflow limitation, history of exacerbations and Circulating eosinophils in COPD patients. BMC Pulm Med. . 19 (1), 112 (2019).","journal-title":"BMC Pulm Med. D\u00e9c"},{"key":"14994_CR43","doi-asserted-by":"crossref","unstructured":"Perotin, J. M. et al. High blood eosinophil count at stable state is not associated with airway microbiota distinct profile in COPD. Int. J. Chron. Obstruct Pulmon Dis.  19:765\u2013771 (2024).","DOI":"10.2147\/COPD.S453526"},{"key":"14994_CR44","doi-asserted-by":"crossref","unstructured":"Tangedal, S. et al. Sputum microbiota and inflammation at stable state and during exacerbations in a cohort of chronic obstructive pulmonary disease (COPD) patients. Singanayagam A, \u00e9diteur. PLOS ONE. 17 (9), e0222449 (2019).","DOI":"10.1371\/journal.pone.0222449"},{"issue":"4","key":"14994_CR45","doi-asserted-by":"publisher","first-page":"e0225560","DOI":"10.1371\/journal.pone.0225560","volume":"15","author":"JL Carvalho","year":"2020","unstructured":"Carvalho, J. L. et al. Oral feeding with probiotic Lactobacillus rhamnosus attenuates cigarette smoke-induced COPD in C57Bl\/6 mice: relevance to inflammatory markers in human bronchial epithelial cells. Chu HW, \u00e9diteur. PLOS ONE. 15 (4), e0225560 (2020).","journal-title":"PLOS ONE 24 Avr"},{"issue":"1\u20132","key":"14994_CR46","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ijfoodmicro.2010.03.013","volume":"141","author":"S Salva","year":"2010","unstructured":"Salva, S., Villena, J. & Alvarez, S. Immunomodulatory activity of Lactobacillus rhamnosus strains isolated from goat milk: impact on intestinal and respiratory infections. Int. J. Food Microbiol. . 141 (1\u20132), 82\u201389 (2010).","journal-title":"Int. J. Food Microbiol. 30 Juin"},{"key":"14994_CR47","doi-asserted-by":"crossref","unstructured":"Hua, J. et al. feng, tu, ran, Prevention of exacerbation in patients with moderate-to-very severe COPD with the intent to modulate respiratory microbiome: a pilot prospective, multi-center, randomized controlled trial. Front Med. 10, 1265544. (2024).","DOI":"10.3389\/fmed.2023.1265544"},{"key":"14994_CR48","doi-asserted-by":"publisher","first-page":"102428","DOI":"10.1016\/j.mib.2024.102428","volume":"77","author":"ZG Drigot","year":"2024","unstructured":"Drigot, Z. G. & Clark, S. E. Insights into the role of the respiratory tract Microbiome in defense against bacterial pneumonia. Curr. Opin. Microbiol. F\u00e9vr. 77, 102428 (2024).","journal-title":"Curr. Opin. Microbiol. F\u00e9vr"},{"issue":"1","key":"14994_CR49","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/s12866-016-0843-z","volume":"16","author":"J Manning","year":"2016","unstructured":"Manning, J. et al. Investigation of Streptococcus salivarius-mediated Inhibition of Pneumococcal adherence to pharyngeal epithelial cells. BMC Microbiol. . 16 (1), 225 (2016).","journal-title":"BMC Microbiol. D\u00e9c"},{"issue":"1","key":"14994_CR50","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/j.1574-695X.2012.00928.x","volume":"65","author":"M Santagati","year":"2012","unstructured":"Santagati, M., Scillato, M., Patan\u00e8, F., Aiello, C. & Stefani, S. Bacteriocin-producing oral Streptococci and Inhibition of respiratory pathogens. FEMS Immunol. Med. Microbiol. . 65 (1), 23\u201331 (2012).","journal-title":"FEMS Immunol. Med. Microbiol. Juin"},{"key":"14994_CR51","doi-asserted-by":"publisher","first-page":"1144157","DOI":"10.3389\/fcimb.2023.1144157","volume":"13","author":"SN Stoner","year":"2023","unstructured":"Stoner, S. N., Baty, J. J., Novak, L. & Scoffield, J. A. Commensal colonization reduces Pseudomonas aeruginosa burden and subsequent airway damage. Front. Cell. Infect. Microbiol.. 13, 1144157 (2023).","journal-title":"Front. Cell. Infect. Microbiol. 25 Mai"},{"key":"14994_CR52","doi-asserted-by":"crossref","unstructured":"J\u00f6rissen, J. et al. Case-Control Microbiome Study of Chronic Otitis Media with Effusion in Children Points at Streptococcus salivarius as a Pathobiont-Inhibiting Species. mSystems 6(2), 10\u20131128 (2021).","DOI":"10.1128\/msystems.00056-21"},{"issue":"51","key":"14994_CR53","doi-asserted-by":"publisher","first-page":"20529","DOI":"10.1073\/pnas.0709804104","volume":"104","author":"JK Harris","year":"2007","unstructured":"Harris, J. K. et al. Molecular identification of bacteria in Bronchoalveolar lavage fluid from children with cystic fibrosis. Proc. Natl. Acad. Sci.. 104 (51), 20529\u201320533 (2007).","journal-title":"Proc. Natl. Acad. Sci. 18 D\u00e9c"},{"issue":"3","key":"14994_CR54","first-page":"e01813","volume":"59","author":"CS Thornton","year":"2021","unstructured":"Thornton, C. S. & Surette, M. G. Potential contributions of anaerobes in cystic fibrosis airways. Kraft CS, \u00e9diteur. J. Clin. Microbiol. . 59 (3), e01813\u2013e01819 (2021).","journal-title":"J. Clin. Microbiol. 18 F\u00e9vr"},{"issue":"4","key":"14994_CR55","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1136\/thoraxjnl-2017-210741","volume":"73","author":"Z Wang","year":"2018","unstructured":"Wang, Z. et al. Sputum Microbiome Temporal variability and dysbiosis in chronic obstructive pulmonary disease exacerbations: an analysis of the COPDMAP study. Thorax . 73 (4), 331\u2013338 (2018).","journal-title":"Thorax Avr"},{"issue":"3","key":"14994_CR56","first-page":"00168","volume":"6","author":"EO Leiten","year":"2020","unstructured":"Leiten, E. O. et al. The airway microbiota and exacerbations of COPD. ERJ Open. Res.. 6 (3), 00168\u20132020 (2020).","journal-title":"ERJ Open. Res. Juill"},{"issue":"1","key":"14994_CR57","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s12931-019-1085-z","volume":"20","author":"Z Wang","year":"2019","unstructured":"Wang, Z. et al. Airway host-microbiome interactions in chronic obstructive pulmonary disease. Respir Res.. 20 (1), 113 (2019).","journal-title":"Respir Res. D\u00e9c"},{"issue":"2","key":"14994_CR58","doi-asserted-by":"publisher","first-page":"000754","DOI":"10.1099\/mgen.0.000754","volume":"8","author":"KA Webb","year":"2022","unstructured":"Webb, K. A. et al. Genomic diversity and antimicrobial resistance of prevotella species isolated from chronic lung disease airways. Microb. Genomics. 8 (2), 000754 (2022).","journal-title":"Microb. Genomics"},{"key":"14994_CR59","doi-asserted-by":"publisher","first-page":"106335","DOI":"10.1016\/j.micpath.2023.106335","volume":"184","author":"X Mao","year":"2023","unstructured":"Mao, X. et al. Analysis of sputum microbial flora in chronic obstructive pulmonary disease patients with different phenotypes during acute exacerbations. Microb. Pathog . 184, 106335 (2023).","journal-title":"Microb. Pathog Nov"},{"issue":"5","key":"14994_CR60","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s00284-005-0261-1","volume":"52","author":"M Yanagisawa","year":"2006","unstructured":"Yanagisawa, M., Kuriyama, T., Williams, D. W., Nakagawa, K. & Karasawa, T. Proteinase activity of prevotella species associated with oral purulent infection. Curr. Microbiol.. 52 (5), 375\u2013378 (2006).","journal-title":"Curr. Microbiol. Mai"},{"key":"14994_CR61","doi-asserted-by":"crossref","unstructured":"Hazra, D. et al. The altered sputum Microbiome profile in patients with moderate and severe COPD exacerbations, compared to the healthy group in the Indian population. F1000Research 12, 528 (2023).","DOI":"10.12688\/f1000research.132220.4"},{"issue":"4","key":"14994_CR62","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1111\/resp.13032","volume":"22","author":"JM Leung","year":"2017","unstructured":"Leung, J. M. et al. The role of acute and chronic respiratory colonization and infections in the pathogenesis of COPD. Respirology. 22 (4), 634\u2013650 (2017).","journal-title":"Respirol. Mai"},{"issue":"9","key":"14994_CR63","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1136\/thoraxjnl-2015-207235","volume":"71","author":"GG Einarsson","year":"2016","unstructured":"Einarsson, G. G. et al. Community dynamics and the lower airway microbiota in stable chronic obstructive pulmonary disease, smokers and healthy non-smokers. Thorax. 71 (9), 795\u2013803 (2016).","journal-title":"Thorax Sept"},{"issue":"12","key":"14994_CR64","doi-asserted-by":"publisher","first-page":"4217","DOI":"10.1128\/JCM.01967-14","volume":"52","author":"M Garcia-Nu\u00f1ez","year":"2014","unstructured":"Garcia-Nu\u00f1ez, M. et al. Severity-Related changes of bronchial Microbiome in chronic obstructive pulmonary disease. Munson E, \u00e9diteur. J. Clin. Microbiol.. 52 (12), 4217\u20134223 (2014).","journal-title":"J. Clin. Microbiol. D\u00e9c"},{"issue":"7","key":"14994_CR65","doi-asserted-by":"publisher","first-page":"e22702","DOI":"10.1371\/journal.pone.0022702","volume":"6","author":"CD Sibley","year":"2011","unstructured":"Sibley, C. D. et al. Culture enriched molecular profiling of the cystic fibrosis airway microbiome. Planet PJ, \u00e9diteur. PLoS ONE . 6 (7), e22702 (2011).","journal-title":"PLoS ONE 28 Juill"},{"key":"14994_CR66","doi-asserted-by":"crossref","unstructured":"Abellan-Schneyder, I. et al. Primer, Pipelines, Parameters: Issues in 16S rRNA Gene Sequencing. mSphere. 6(1):e01202-20 (2021).","DOI":"10.1128\/mSphere.01202-20"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14994-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14994-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14994-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T14:03:48Z","timestamp":1758809028000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14994-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,25]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14994"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-14994-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6206453\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,25]]},"assertion":[{"value":"11 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"J.M. Perotin reports lecture honoraria from AstraZeneca, and support for attending meetings from AstraZeneca and Chiesi, outside the submitted work. G. Desl\u00e9e reports lecture honoraria from Chiesi, AstraZeneca and GlaxoSmithKline; outside the submitted work. S. Dury reports fees from Boehringer-Ingelheim and Sanofi-Adventis, outside the submitted work. Rest of the authors have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"This research was conducted in accordance with the Declaration of Helsinki, followed the rules applicable to medical research in France, and received the authorization needed. The study was approved by the regional ethics committee (Comit\u00e9 de Protection des Personnes\u2014Dijon EST I, no. 2016-A00242-49). Informed consent was obtained from all the patients.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and informed consent"}}],"article-number":"32767"}}